Head-to-head · Cost-Efficiency Index
Injectco vs Mochi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Injectco
Cost-first shoppers who want texas-area patients comfortable prepaying a lump sum for a 6-8 month supply without the page specifying which drug they're buying.
Visit InjectcoMochi Health
Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Visit Mochi HealthThe verdict
Injectco and Mochi Health tie on the Cost-Efficiency Index at 56/100, so neither wins outright on the numbers. For most shoppers we'd start with Injectco (ranked #325, a hair above #330) — Cost-first shoppers who want texas-area patients comfortable prepaying a lump sum for a 6-8 month supply without the page specifying which drug they're buying. But Mochi Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Injectco.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Injectco | Mochi Health |
|---|---|---|
| Cost-Efficiency Index | 56/100 | 56/100 |
| Semaglutide / mo | $156/mo (starting dose, prepay plan, compounded) | $178/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $156/mo (starting dose, prepay plan, compounded) | $278/mo (starting dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,872 | $2,136 |
| Tirzepatide / yr (modeled) | $1,872 | $3,336 |
| Coverage | Coverage not published | 15 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #325 | #330 |
Injectco
56/100Where the value is
- Bulk pricing ($1,249 for 6-8 months) works out cheaper per month than many monthly-billed competitors, if the buyer needs that long a supply
- Interest-free-style payment plan breaks the lump sum into ~$156 installments
- HSA/FSA eligible with itemized receipts for reimbursement
The tradeoffs
- The page never specifies whether the price is for semaglutide or tirzepatide — a shopper cannot tell which medication $1,249 buys them
- '$156/month' is a prepaid-order installment, not a true recurring subscription price — the actual commitment is $1,249 up front for 6-8 months
Mochi Health
56/100Where the value is
- Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
- Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
- Membership includes ongoing care-team messaging and coaching, not just a one-time prescription
The tradeoffs
- The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
- No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.